Analysis of SMYD3 mRNA expression in HCC and adjacent non-tumor liver tissues showed that it is upregulated in HCC tumor tissues compared to paired normal tissues [21], with overexpression positively correlating with invasion, poor tumor differentiation, high TNM stage and a poor prognosis for patients with early-stage disease [20,21]. The gene discussed is SMYD3; the disease is hepatocellular carcinoma.